Lisa Schopf
About
In The Last Decade
Lisa Schopf
32 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 95
- Immunology 866
- Parasitology 634
- Public Health, Environmental and Occupational Health 365
- Infectious Diseases 320
- Epidemiology 319
Countries citing papers authored by Lisa Schopf
This map shows the geographic impact of Lisa Schopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Schopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Schopf more than expected).
Fields of papers citing papers by Lisa Schopf
This network shows the impact of papers produced by Lisa Schopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Schopf. The network helps show where Lisa Schopf may publish in the future.
Co-authorship network of co-authors of Lisa Schopf
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Schopf. A scholar is included among the top collaborators of Lisa Schopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Schopf. Lisa Schopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | Enhanced Topical Delivery of a Novel Loteprednol Etabonate Ophthalmic Formulation | 1 |
| 3 | 52 | |
| 4 | Enhanced Topical Delivery of a Small Molecule Receptor Tyrosine Kinase Inhibitor (RTKi) via Mucosal-Penetrating Particle Technology | 2 |
| 5 | 101 | |
| 6 | 39 | |
| 7 | 59 | |
| 8 | 397 | |
| 9 | 22 | |
| 10 | 78 | |
| 11 | 1 | |
| 12 | 43 | |
| 13 | 163 | |
| 14 | 160 | |
| 15 | 37 | |
| 16 | 181 | |
| 17 | 50 | |
| 18 | The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. | 61 |
| 19 | 46 | |
| 20 | 89 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.